Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker [Original Article]

Conclusions—
The present study suggests that myocardial Gal-3 can be considered as a possible marker for both cardiac inflammation and fibrosis, depending on the pathogenesis of heart failure. However, circulating concentrations of Gal-3 do not seem to reflect endomyocardial Gal-3 levels or cardiac fibrosis.

Source: Circulation: Heart Failure - March 12, 2017 Category: Cardiology Authors: Besler, C., Lang, D., Urban, D., Rommel, K.-P., von Roeder, M., Fengler, K., Blazek, S., Kandolf, R., Klingel, K., Thiele, H., Linke, A., Schuler, G., Adams, V., Lurz, P. Tags: Biomarkers, Fibrosis, Cardiomyopathy, Heart Failure, Inflammatory Heart Disease Original Article Source Type: research